Dr. Friedman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Lowder 512
Houston, TX 77030Phone+1 713-792-6620Fax+1 713-794-5042
Summary
- Dr. Gregory Friedman is a pediatric hematologist/oncologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. He received his medical degree from Medical College of Georgia and has been in practice 15 years. He specializes in pediatric neuro-oncology and is experienced in glioblastoma, medulloblastoma, immunotherapy, gliomas, and pediatric brain tumors. He has more than 90 publications and over 500 citings.
Education & Training
- University of Alabama Medical CenterFellowship, Pediatric Hematology/Oncology, 2005 - 2008
- University of Alabama Medical CenterResidency, Pediatrics, 2002 - 2005
- Medical College of Georgia at Augusta UniversityClass of 2002
Certifications & Licensure
- TX State Medical License 2023 - 2026
- AL State Medical License 2003 - 2023
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors Start of enrollment: 2016 May 01
- Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Start of enrollment: 2019 May 17
- HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors Start of enrollment: 2019 Sep 12
- Join now to see all
Publications & Presentations
PubMed
- STAT5 activation enhances adoptive therapy combined with peptide vaccination by preventing PD-1 inhibition.Aaron E Fan, Hussein Sultan, Takumi Kumai, Valentyna I Fesenkova, Juan Wu
Molecular Cancer Therapeutics. 2024-11-25 - Immunotherapy-Related Neurotoxicity in the Central Nervous System of Children with Cancer.Jiasen He, Jeremy Connors, Andrew Meador, Shuo Xu, Heather Meador
Neuro-Oncology. 2024-11-13 - 1 citationsCHD2 Regulates Neuron-Glioma Interactions in Pediatric Glioma.Xu Zhang, Shoufu Duan, Panagiota E Apostolou, Xiaoping Wu, Jun Watanabe
Cancer Discovery. 2024-09-04
Journal Articles
- Original Article Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of HSV-1 G207 in Pediatric Malignant Supratentorial Brain TumorsAsim K Bag, G Yancey Gillespie, Gregory K Friedman, Zachary Wright, James M Markert, James M Johnston, ScienceDirect
- UAB30, a Novel RXR Agonist, Decreases Tumorigenesis and Leptomeningeal Disease in Group 3 Medulloblastoma Patient-Derived XenograftsGregory K Friedman, Evan F Garner, Laura L Stafman, Journal of Neuro-Oncology
Press Mentions
- Treovir Announces Opening of G207 Phase 2 Clinical Trial in Children with Recurrent Brain TumorsDecember 4th, 2024
- 2 Your Health: Study Links Gut Microbiome and Aggressive Prostate CancerNovember 11th, 2021
- UAB-Developed Viral Immunotherapy for Pediatric Brain Tumors Shows PromiseMay 2nd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: